Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.39 |
| ▸ | PER2 | O15055 | 1/20 | 0.38 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.38 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NPY1R | P25929 | 1/20 | 0.35 |
| ▸ | NPY2R | P49146 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20686442 | 0.83 | GPR3 (0.39) | BCHEACHEPOLBTSHRNPY1R | |
| SCHEMBL12091659 | 0.80 | GPR3 (0.46) | BCHEACHEPOLBTSHRNPY1R | |
| SCHEMBL19785435 | 0.80 | POLB (0.37) | BCHEACHEPOLBTSHRNPY1R | |
| SCHEMBL16786129 | 0.79 | TSHR (0.36) | BCHEACHEPOLBLMNATSHR | |
| SCHEMBL14600984 | 0.76 | FAAH (0.34) | PER2CRY1CRY2BCHEACHE | |
| SCHEMBL25526924 | 0.74 | GPR3 (0.40) | BCHEACHEPOLBTSHRNPY1R | |
| SCHEMBL14523557 | 0.74 | FAAH (0.33) | PER2CRY1CRY2BCHEACHE | |
| SCHEMBL20841225 | 0.72 | GPR3 (0.41) | BCHEACHEPOLBTSHRNPY1R | |
| SCHEMBL13325073 | 0.72 | TRPA1 (0.44) | TRPA1PER2CRY1CRY2POLB | |
| SCHEMBL18951654 | 0.71 | GPR3 (0.38) | PER2BCHEACHEPOLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8147986-B2 | Organic electroluminescent device | FUJIFILM CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-7713595-B2 | birefrigence; chromophores; abrasion resistance | NITTO DENKO CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7479309-B2 | Multi-layered compensation film using specified Tg material as a birefringent layer | NITTO DENKO CORPORATION (JP) | 2009-01-20 | — | — | US | disclosed |
| US-20070087132-A1 | Optical compensation films produced by a carrier-web-casting process | EASTMAN KODAK COMPANY | 2007-04-19 | — | — | US | disclosed |
| US-20070075311-A1 | Organic electroluminescent device | FUJI PHOTO FILM CO., LTD. | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070075311-A1 | Organic electroluminescent device | L1CAM, DCX, ORC3 | TRPA1 618/4885TAAR1 2827/4885PER2 3298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.